Importance of Susceptibility Rate of 'the First' Isolate: Evidence of Real-World Data
- PMID: 32998192
- PMCID: PMC7600976
- DOI: 10.3390/medicina56100507
Importance of Susceptibility Rate of 'the First' Isolate: Evidence of Real-World Data
Abstract
Background and objectives: For proper antimicrobial therapy, cumulative antibiograms should be representative of geographic region and be accurate. Clinical and Laboratory Standards Institute (CLSI) guidelines recommend that only the first isolates (FI) of a species per patient are used when reporting cumulative antibiograms. However, >50% of hospitals in the United States report antibiograms of all isolates. We compared antibiograms from the FI with those from total isolates (TI). Materials and Methods: Antimicrobial data of all isolates identified in the Microbiology unit of Ilsan Paik Hospital in 2019 were retrospectively acquired from the hospital information system. The susceptibility rates to antimicrobials of Escherichia coli, Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus faecium, and Enterococcus faecalis were analyzed by FI and TI, respectively. Isolate counts and susceptibility rates of each species for the reported antimicrobials were compared. Results: The numbers of isolates by FI/TI were as follows: 1824/2692 E. coli, 480/1611 A. baumannii, and 662/1306 K. pneumoniae, and 407/953 P. aeruginosa for gram-negative bacteria and 649/1364 S. aureus, 211/313 E. faecium, and 323/394 E. faecalis for gram-positive bacteria. All antimicrobial agents showed higher susceptibility rates when calculated as FI than as TI in gram-negative bacteria except colistin: 3.7% for E. coli, 14.5% for A. baumannii, 8.3% for K. pneumoniae, and 7.9% for P. aeruginosa. In S. aureus, 8/11 antimicrobial agents revealed higher susceptibility rates for FI than for TI. E. faecalis and E. faecium showed lower susceptibility rates for 7/10 antimicrobial agents for FI than for TI. The oxacillin susceptibility rates of S. aureus were 36.6%/30.2% with FI/TI and vancomycin susceptibility rates for E. faecium were 54.1% and 49.5%, respectively. Conclusions: When comparing cumulative antibiograms by FI with TI using real-world data, there is a large gap for critical species requiring hospital infection control. Although FI calculation is difficult, antibiograms must be calculated as FI for proper preemptive antimicrobial therapy because FI provides proper antimicrobial susceptibility data.
Keywords: antimicrobial agent; cumulative antibiogram; empirical therapy; first isolate; susceptibility.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.Clin Ther. 2008 Nov;30(11):2040-50. doi: 10.1016/j.clinthera.2008.11.006. Clin Ther. 2008. PMID: 19108792
-
Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.Ann Clin Microbiol Antimicrob. 2017 Jul 12;16(1):50. doi: 10.1186/s12941-017-0222-0. Ann Clin Microbiol Antimicrob. 2017. PMID: 28701170 Free PMC article.
-
[Surveillance of resistance in the intensive care units using a cumulative antibiogram].Mikrobiyol Bul. 2018 Oct;52(4):329-339. doi: 10.5578/mb.67408. Mikrobiyol Bul. 2018. PMID: 30522419 Turkish.
-
Systematic review of antibiograms: A National Laboratory System approach for improving antimicrobial susceptibility testing practices in Michigan.Public Health Rep. 2010 May-Jun;125 Suppl 2(Suppl 2):63-72. doi: 10.1177/00333549101250S208. Public Health Rep. 2010. PMID: 20518446 Free PMC article.
-
What's New in Antibiograms? Updating CLSI M39 Guidance with Current Trends.J Clin Microbiol. 2022 Oct 19;60(10):e0221021. doi: 10.1128/jcm.02210-21. Epub 2022 Aug 2. J Clin Microbiol. 2022. PMID: 35916520 Free PMC article. Review.
Cited by
-
Analysis of Cumulative Antibiogram Reports in Search for Optimal Empirical Urinary Tract Infection Treatment at the Central Teaching Hospital of the Medical University of Lodz, Poland: Results of a 3-Year Surveillance.J Clin Med. 2023 Sep 28;12(19):6270. doi: 10.3390/jcm12196270. J Clin Med. 2023. PMID: 37834914 Free PMC article.
-
Recovery of antimicrobial susceptibility in methicillin-resistant Staphylococcus aureus (MRSA): a retrospective, epidemiological analysis in a secondary care hospital, Sapporo, Japan.PeerJ. 2021 Jun 21;9:e11644. doi: 10.7717/peerj.11644. eCollection 2021. PeerJ. 2021. PMID: 34221728 Free PMC article.
-
Better antimicrobial resistance data analysis and reporting in less time.JAC Antimicrob Resist. 2023 Jan 18;5(1):dlac143. doi: 10.1093/jacamr/dlac143. eCollection 2023 Feb. JAC Antimicrob Resist. 2023. PMID: 36686270 Free PMC article.
-
Combining Genome Surveillance and Metadata To Characterize the Diversity of Staphylococcus aureus Circulating in an Italian Hospital over a 9-Year Period.Microbiol Spectr. 2023 Aug 17;11(4):e0101023. doi: 10.1128/spectrum.01010-23. Epub 2023 Jul 17. Microbiol Spectr. 2023. PMID: 37458594 Free PMC article.
References
-
- Choi S.-H., Lee J.E., Park S.J., Choi S.-H., Lee S.-O., Jeong J.-Y., Kim M.-N., Woo J.H., Kim Y.S. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC β-Lactamase: Implications for antibiotic use. Antimicrob. Agents. Chemother. 2008;52:995–1000. doi: 10.1128/AAC.01083-07. - DOI - PMC - PubMed
-
- Clinical and Laboratory Standards Institute (CLSI) Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data. 4th ed. CLSI; Wayne, PA, USA: 2014. Approved Guideline. M39-A4.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous